Today, small biotechnology companies that are in the business of developing highly complex, biologically potent drugs in clinical development know that they face a difficult task. Reaching for and actually grabbing hold of the bar of success is never easy and is, in fact, getting harder. But there is help in the form of a CDMO. Paul Nelles, Ph.D., Vice President of Vetter Development Services offers his thoughts on how a CDMO can help you reach for, and actually grab hold of the bar of success in the Spring issue of International Pharmaceutical Industry.
Grabbing Hold of the Bar of Success in Drug Development
International Pharmaceutical Industry, Spring 2013, Volume 5, Issue 2